Mr. Chopra
Corporate Vice President, Transcatheter Mitral And Tricuspid Therapies
Edwards Lifesciences Corp · EW
$4.7M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A filed March 26, 2026. Prior years are from that filing's three-year table.
Catalog as of September 15, 2026. Not a live market feed.
- Salary
- $671K
- Stock Awards
- $1.8M
- Option Awards
- $1.4M
- Incentives
- $824K
- Other
- $61K
Compensation History
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $671,042 | $1,764,066 | $4,695,742 |
| 2024 | $627,346 | $1,284,500 | $3,720,491 |
Current Position
- Company
- Edwards Lifesciences Corp
- Title
- Corporate Vice President, Transcatheter Mitral And Tricuspid Therapies
- Ticker
- EW · NYSE
- Fiscal Year
- 2025
SEC Sources
Fiscal years below are columns from the latest DEF 14A Summary Compensation Table (filed March 26, 2026), not separate historical filings.
| Fiscal Year | Source |
|---|---|
| 2025 | View SEC filing |
| 2024 | View SEC filing |
Accession 0001099800-26-000015.
Other Edwards Lifesciences Executives
Mr. Zovighian
Chief Executive Officer And Director
Edwards Lifesciences · EW
$17.5M
FY 2025 · DEF 14A
Mr. Ullem
Corporate Vice President, Chief Financial Officer
Edwards Lifesciences · EW
$6.1M
FY 2025 · DEF 14A
Mr. Bobo
Corporate Vice President, Strategy & Corporate Development
Edwards Lifesciences · EW
$4.2M
FY 2025 · DEF 14A
Ms. Brüls
Edwards Lifesciences · EW
$3.7M
FY 2025 · DEF 14A
Mr. Wood
Former Corporate Vice President And Group President, Transcatheter Aortic Valve Replacement And Surgical Structural Heart
Edwards Lifesciences · EW
$4.9M
FY 2025 · DEF 14A